We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.38B
AUM Growth
-$101M
Cap. Flow
-$196M
Cap. Flow %
-8.23%
Top 10 Hldgs %
21.35%
Holding
276
New
33
Increased
38
Reduced
163
Closed
29

Sector Composition

1 Technology 24.67%
2 Healthcare 22.79%
3 Industrials 22.78%
4 Financials 9.47%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCPH
276
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-1,044,871
Closed -$16.4M

Similar funds

Emerald Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Emerald Advisers held 276 positions worth $2.38B, down 4.1% from $2.49B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers withdrew a net $196M in Q2 2024, closing 29 positions and reducing 163 holdings. Its most notable exit was Treace Medical Concepts, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Emerald Advisers opened a new position in Modine Manufacturing worth $26.1M.

  • Emerald Advisers's largest Q2 2024 buy was Modine Manufacturing: 260,150 shares worth $26.1M.
  • Emerald Advisers added most to InterDigital in Q2 2024, an estimated $12.9M increase.
  • Emerald Advisers's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $75.9M.
  • Emerald Advisers fully exited Treace Medical Concepts in Q2 2024, selling an estimated $20.4M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.38B portfolio in Q2 2024.
  • Emerald Advisers opened 33 new positions and closed 29 in Q2 2024.
  • Emerald Advisers's portfolio value fell 4.1% quarter-over-quarter to $2.38B.

Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.